Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.12 +0.05 (+1.60%)
As of: Oct 21, 2026 · 3:44 PM EDT

Galmed Pharmaceuticals (EOCN) EV to EBIT (2014 - 2024)

Updated

Galmed Pharmaceuticals' (EOCN) EV to EBIT came in at -5.66 for FY2025, compared with -2.17 in FY2024.

Analysis

Galmed Pharmaceuticals (EOCN) EV to EBIT (2014 - 2024) Analysis & Trends

Since FY2014, Galmed Pharmaceuticals has reported EV to EBIT for 12 years.

  • The FY2025 figure stands as the lowest annual EV to EBIT in data going back to FY2014.
  • Business Quant data shows EOCN's EV to EBIT at -2.17 in FY2024, -1.23 in FY2023, -0.12 in FY2022 and 0.20 in FY2021 (-39.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,135.76 Bn 1,104.34 Bn 19.71 Bn
2 Johnson & Johnson 619.07 Bn 537.60 Bn 17.26 Bn
3 AbbVie 503.11 Bn 476.22 Bn 12.70 Bn
4 Merck 370.23 Bn 324.61 Bn 12.21 Bn
5 Novartis Ag 298.76 Bn 262.75 Bn 11.24 Bn
6 Astrazeneca 261.14 Bn 234.83 Bn 12.86 Bn
7 Amgen 237.54 Bn 192.94 Bn 7.24 Bn
8 Gilead Sciences 191.65 Bn 165.84 Bn 6.22 Bn
9 Pfizer 170.26 Bn 116.90 Bn 10.94 Bn
10 Galmed Pharmaceuticals 1.68 Mn -39.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 9.60
Jun 30, 2023 42,651.84
Jun 30, 2022 4,271.18
Sep 30, 2017 2,473.43
Jun 30, 2017 1,485.10
Mar 31, 2017 666.46
Dec 31, 2016 454.49
Sep 30, 2016 572.86
Jun 30, 2016 633.10
Mar 31, 2016 789.44
Dec 31, 2015 1,397.82
Sep 30, 2015 1,548.55
Jun 30, 2015 1,955.18
Mar 31, 2015 1,978.09
Dec 31, 2014 1,264.40
API Access

Galmed Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=EOCN&period=max&api_key=YOUR_API_KEY